Treatment with non-selective beta-blockers affects the systemic inflammatory response to bacterial DNA in patients with cirrhosis.
Por:
Gimenez, P, Garcia-Martinez, I, Frances, R, Gonzalez J, Mauri M, Alfayate R, Almenara S, Miralles C, Palazon J, Carnicer F, Pascual, S, Such, J, Horga J and Zapater, P
Publicada:
1 dic 2018
Categoría:
Hepatology
Resumen:
The use of non-selective beta-blockers has been associated with lower rates of infection and reduced infection-associated morbidity in patients with cirrhosis. However, it is unknown if these drugs modify the systemic inflammatory response to circulating bacterial DNA.
|